Ivers-Lee takes advantage of Kistler's integrated force-displacement monitoring in its assembly lines for drug-device combination products. Sensors and process monitoring systems operate in the final stage of the assembly process for auto-injectors and pen systems, ensuring that these self-medication products meet the highest quality standards.
Thanks to advances in the medtech and pharmaceutical industries, patients can now manage the treatment of many conditions themselves. One example is diabetes, a disease whose incidence is on the rise amid growing affluence – and not infrequently the result of a combination of an unbalanced diet and too little exercise. Self-management of this and many other conditions is more comfortable for the patient, and saves trips to the doctor; however, this requires totally reliable, user-friendly devices of the highest quality.
Nevertheless, many hurdles need to be overcome before a suitable product is approved for commercial marketing. Above all, clinical studies must be carried out to verify the efficacy of the drug; such studies are very costly and extremely time consuming. To streamline the obligatory processes and reduce time-to-market for their products, many pharmaceutical manufacturers invite Ivers-Lee to come on board. This Swiss company can look back on a long tradition of leadership in its field. It has a workforce of 100 at its headquarters in Burgdorf near Bern and another 10 employees at its site in Lörrach, Germany.